NCT06976164 Reflexo Therapy for Gestational Diabetes Mellitus
| NCT ID | NCT06976164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Physical Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-05-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.
Eligibility Criteria
Inclusion Criteria: 1. They were maternally aged between 20 and 35 years. 2. The gestational age ranged from between 24 and 36 weeks. 3. Their BMI didn't exceed 30 kg/m2. 4. A singleton live fetus and not under stressful event. Exclusion Criteria 1. They had high-risk pregnancies. 2. Bad obstetric situations. 3. Diseases that could interfere with participation. 4. Smoking. 5. Oral sedative administration.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06976164 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 35 Years, studying Physical Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06976164 currently recruiting?
Yes, NCT06976164 is actively recruiting participants. Contact the research team at youmna.ezz_a012@pt.kfs.edu.eg for enrollment information.
Where is the NCT06976164 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT06976164 clinical trial?
NCT06976164 is sponsored by Kafrelsheikh University. The trial plans to enroll 36 participants.